BEAM Overview
Upcoming Projects (BEAM)
Executed Projects (BEAM)
-
Discussing Beam Therapeutics' Phase 1/2 results for BEAM-302 for patients with AATD.
Ticker: BEAM
Executed On: May 21, 2025 at 12:00 PM EDT -
Discussing Beam's recent BEACON and ESCAPE data for BEAM-101 in Sickle Cell Disease presented at ASH 2024
Ticker: BEAM
Executed On: Jan 06, 2025 at 10:00 AM EST
Expired Projects (BEAM)
-
Analyzing the Phase 1/2 Study Results for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) from Beam Therapeutics
Ticker: BEAM
Execute By: Sep 30, 2025
Upcoming & Overdue Catalysts (BEAM)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (BEAM)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
